Treatment of Hypertension-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

Immediate Management Priorities

The European Heart Journal recommends immediate blood pressure reduction using intravenous labetalol or nicardipine with a target of 20-25% mean arterial pressure reduction within the first hour for patients with hypertensive PRES, requiring ICU admission with continuous arterial monitoring 1, 2, 3
The European Society of Cardiology suggests that all patients with hypertensive PRES require immediate ICU admission with continuous arterial blood pressure monitoring, which is a Class I recommendation 2, 3, 4
Continuous neurological monitoring is essential, assessing for altered mental status, visual changes, seizure activity, and progression of symptoms, as recommended by the European Heart Journal 3, 4
MRI with FLAIR or T2-weighted sequences should be obtained to confirm the diagnosis, showing characteristic increased signal intensity in posterior white matter regions that are fully reversible with treatment, according to the European Heart Journal 1, 4

The European Heart Journal provides specific targets for blood pressure reduction: reduce mean arterial pressure by 20-25% immediately, then to 160/100 mmHg within 2-6 hours, and cautiously normalize blood pressure within 24-48 hours 1, 2, 4
The American Heart Association recommends avoiding excessive acute drops exceeding 70 mmHg systolic, as patients with chronic hypertension have altered cerebral autoregulation and cannot tolerate acute normalization 1, 2, 3

The European Heart Journal suggests that nicardipine is the optimal first-line agent for hypertensive PRES because it maintains cerebral blood flow and does not increase intracranial pressure, with an initial dose of 5 mg/hr IV infusion and titration to a maximum of 15 mg/hr 2, 3, 4
The American College of Cardiology recommends labetalol as an excellent alternative first-line agent, with bolus dosing of 0.25-0.5 mg/kg IV bolus and continuous infusion of 2-4 mg/min until goal BP reached, then 5-20 mg/hr maintenance 1, 2, 3

The European Heart Journal explains that PRES develops when markedly elevated blood pressure exceeds cerebral autoregulation capacity, particularly in posterior brain regions, leading to cerebral edema, microscopic hemorrhages, and potential infarctions if untreated 1, 5
The white matter lesions are fully reversible with timely recognition and appropriate blood pressure management, as stated by the European Heart Journal 1, 4

The European Society of Hypertension recommends screening for secondary hypertension causes after stabilization, as 20-40% of malignant hypertension cases have identifiable secondary causes, including medication non-adherence, sympathomimetics or cocaine use, and renal artery stenosis 1, 3

The American Heart Association suggests that after acute stabilization, transition to oral antihypertensive therapy should be gradual, using combination therapy with RAS blockers, calcium channel blockers, and diuretics, with a target systolic blood pressure of 120-129 mmHg for most adults to reduce long-term cardiovascular risk 3